[Prevalence of dyslipidemia in outpatients of the Spanish health service: the HISPALIPID Study].
OBJECTIVE
We intended to estimate the prevalence of dyslipidemia among patients attending outpatient clinics of the Spanish health service.


METHODS
HISPALIPID is a multicenter, cross-sectional study performed in 33,913 patients (55.7% women) with a mean age of 54.6 +/- 18.3 years attended in outpatient clinics across 15 of the 17 autonomous communities of Spain. 1,461 physicians (78.8% primary care physicians, and 21.2% specialists) participated in the study. Patients were considered having dyslipidemia if their doctor had established a previous diagnosis.


RESULTS
A total of 8,256 patients (52.4% women, mean age 62.4 +/- 12.4 years) had been diagnosed with dyslipidemia, representing a global prevalence of 24.3% (CI95%: 23.8-24.8) (M: 26.2%; W:22.9%; P<0.001). The communities with the higher and lower prevalence were the Canary Islands (33.9%) and Cantabria (18.6%), respectively. About 87% dyslipemic patients presented an additional cardiovascular risk factor and 36.7% of dyslipemic patients had an associated cardiovascular disease.


CONCLUSIONS
The prevalence of dyslipidemia is high in patients attending outpatient clinics of the Spanish health service (one out of four patients). In addition, these patients are at a high cardiovascular risk.
Vegazo
Onofre
O
Departamento Médico, AstraZeneca Farmacéutica Spain. Onofre.Vegazo@astrazeneca.com
Banegas
Jose R
JR
Civeira
Fernando
F
Serrano Aisa
Pedro L
PL
Jiménez
F Javier
FJ
Luengo
Emilio
E
D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D015995:Prevalence; D013030:Spain / Q000453:epidemiology